Prostatic Neoplasms: all 6,484 studies
Page 4 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)RecruitingNCT07365423Phase 2
- Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate CancerNot yet recruitingNCT07365397Not applicable
- Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate CancerRecruitingNCT07364071Phase 2
- Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate CancerRecruitingNCT07363486Phase 1/2
- The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate CancerRecruitingNCT07363382Phase 1/2
- Study to Assess the Effect of OCT-598 in Patients With Advanced Solid TumorsRecruitingNCT07358806Phase 1
- Prostate Cancer Early Detection Using Serial MRI ExaminationsNot yet recruitingNCT07355504Not applicable
- Axelopran for Advanced Cancer in Patients Receiving OpioidsRecruitingNCT07354919Phase 2
- Anxiety in Patients Under Active Surveillance for Localized Prostate Cancer and Their Partners.RecruitingNCT07351461
- A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.RecruitingNCT07348367Not applicable
- Adaptive Stereotactic Radiotherapy for Localized Prostate CancerRecruitingNCT07344844Not applicable
- A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical PracticeRecruitingNCT07344779
- Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoringRecruitingNCT07344363
- A Phase I Trial of A-CAR032 in Participants With mCRPCRecruitingNCT07344311Phase 1
- Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 FractionsRecruitingNCT07343349Not applicable
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & EffectivenessRecruitingNCT07339943Not applicable
- A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate CancerRecruitingNCT07339267Phase 1
- Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With AcupunctureRecruitingNCT07335224Not applicable
- Detection of Minimal Residual Disease Post-prostatectomyRecruitingNCT07334275
- Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.RecruitingNCT07333066Phase 3
- Sequential bpMRI for Suspicious Prostate LesionsNot yet recruitingNCT07332832
- First-Time-in-Human Study of GSK5471713 in Adults With mCRPCRecruitingNCT07332455Phase 1/2
- A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecRecruitingNCT07332000Phase 2
- Natural History Study of Early Life Exposures in Agriculture (ELEA)Enrolling by invitationNCT07328516
- Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate CancerRecruitingNCT07325721Phase 2
- Adaptive Radiotherapy for Genitourinary CancersRecruitingNCT07324798Not applicable
- Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of BeijingRecruitingNCT07319923
- A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate CancerRecruitingNCT07319871Phase 1
- Sample Collection for Ongoing Research and Product Evaluation StudyRecruitingNCT07318051
- Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate AdenocarcinomaRecruitingNCT07316686Phase 1
- Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)RecruitingNCT07313241Phase 2
- Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical StudyNot yet recruitingNCT07311915Not applicable
- Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate CancerNot yet recruitingNCT07310433Phase 2
- Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate CancerRecruitingNCT07308990Not applicable
- Cognitive and Fusion Prostatic BiopsyRecruitingNCT07306741Not applicable
- REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)RecruitingNCT07302451Phase 2
- Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized TrialRecruitingNCT07300566Not applicable
- Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)RecruitingNCT07299292Phase 2
- CARE Tool Study Aim 3RecruitingNCT07296887Not applicable
- Targeted And Perilesional Or Systematic Biopsy In Prostate CancerNot yet recruitingNCT07296042Not applicable
- Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray TreatmentRecruitingNCT07293585Phase 3
- A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1RecruitingNCT07292168Phase 1/2
- PSMA-PET Directed Radiation Therapy for High-Risk Prostate CancerNot yet recruitingNCT07291557Phase 2
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer PatientsRecruitingNCT07291414Not applicable
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate CancerNot yet recruitingNCT07290998Not applicable
- Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)RecruitingNCT07290270
- Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsRecruitingNCT07288359Phase 1/2
- Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active SurveillanceRecruitingNCT07285057Phase 2
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- Focal or Radical Therapy: a Lesion-based Molecular Evaluation in Prostate CancerRecruitingNCT07282808Not applicable
- Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019Not yet recruitingNCT07282197Phase 2
- SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot TrialNot yet recruitingNCT07280897Not applicable
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillanceNot yet recruitingNCT07278362Phase 4
- Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE TrialRecruitingNCT07276438Not applicable
- PSMA-PET/MRI-Ultrasound Multimodal Fusion Navigation for Da Vinci Robot-Assisted Radical Prostatectomy: A Randomized Controlled TrialNot yet recruitingNCT07272317Not applicable
- Robot-Assisted Prostate Biopsy With a Novel Ultrasound ProbeRecruitingNCT07271017Phase 1
- CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate CancerNot yet recruitingNCT07268794Phase 2
- Minimal Residual Disease in Solid MalignanciesNot yet recruitingNCT07268469Not applicable
- Virtual Biopsy of Prostate Cancer Using PSMA PET and AIRecruitingNCT07266129
- Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate CancerNot yet recruitingNCT07264088
- Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate CancerRecruitingNCT07260435Phase 3
- GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted BiopsiesRecruitingNCT07258056Not applicable
- Cancer Survivors ProgramRecruitingNCT07253987Not applicable
- Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate CancersRecruitingNCT07252726Phase 4
- A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate CancerRecruitingNCT07250542Phase 2
- MR Microstructural Imaging for Prostate Cancer DiagnosisRecruitingNCT07249281
- The Impact of Force Feedback in the dV5 Robotic Surgical System on Learning Curve and Safety in Robot-Assisted Radical Prostatectomy - A Prospective, Single-Center, Investigator-Initiated Clinical TrialRecruitingNCT07247175Phase 2
- Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate CancerRecruitingNCT07245745Not applicable
- Electroacupuncture for Improving Urinary Incontinence After Radical ProstatectomyNot yet recruitingNCT07245342Not applicable
- Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular ExerciseRecruitingNCT07243834Not applicable
- Ejaculatory Behavior and Seminal Vesicle Size During Radical ProstatectomyNot yet recruitingNCT07243795Not applicable
- 68Ga-XACP3 PET/CT in Prostate CancerRecruitingNCT07242014Not applicable
- A Prospective Evaluation of Early Acupuncture for Immediate Continence Enhancement After ProstatectomyNot yet recruitingNCT07239518Not applicable
- Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate CancerNot yet recruitingNCT07238959
- Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate CancerRecruitingNCT07237269Phase 2
- PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate CancerRecruitingNCT07234981Phase 2
- AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI LesionsRecruitingNCT07231627Not applicable
- Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource SpotsRecruitingNCT07231159
- A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate CancerRecruitingNCT07230106Phase 2
- Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized TrialRecruitingNCT07227077Not applicable
- Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling InhibitorsRecruitingNCT07226713Phase 2
- A Study of Meaning-Centered Therapy for Mexican Adults With Advanced CancerRecruitingNCT07225309Not applicable
- Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)RecruitingNCT07224009Phase 2
- High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)RecruitingNCT07223385Phase 2
- Circulating Tumor DNA in High Risk Localized Prostate CancerRecruitingNCT07222436
- Low-Count Quantitative SPECT for Men Treated With Radium-223RecruitingNCT07221825Not applicable
- POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 LesionsRecruitingNCT07220720Phase 2
- Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate CancerRecruitingNCT07219303Not applicable
- 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate CancerRecruitingNCT07219147Phase 1
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerRecruitingNCT07213674Phase 3
- Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)RecruitingNCT07210086Phase 2
- 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRIRecruitingNCT07209878Phase 2/3
- Physician- and Patient-based Barriers to NGS TestingRecruitingNCT07209176Not applicable
- Real-world Study on Preoperative Application of RezvilutamideNot yet recruitingNCT07208292
- Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)Enrolling by invitationNCT07205783Not applicable
- Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU AblationRecruitingNCT07203482
- Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT TrialRecruitingNCT07202247Phase 2
- Holistic Acupuncture for Patients With Chemotherapy Induced NauseaRecruitingNCT07201194Not applicable
- Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialRecruitingNCT07200830Phase 3